Today, the U.S. Food and Drug Administration approved Miplyffa (arimoclomol), an oral medication for the treatment of Niemann-Pick disease, type C (NPC). Miplyffa, in combination with the enzyme ...

While some nations are burdened with exorbitant prices, others, like South Africa, have managed to keep medication costs low.

The incidence of stroke continues to increase for adults and children living with sickle cell disease despite the Stroke ...

Type 2 diabetes is characterized by the body's inability to use insulin effectively. Insulin is a hormone that helps regulate metabolism properly. The condition is the most common type of ...

Hence, this was an area where many ingredient and process suppliers at IFT First focused. “It is important for the flavor in ...

This shows us that regular physical activity should not be underestimated as an option for reducing the risk of ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Antiplatelets are particularly beneficial for people who have had a previous heart attack or stroke, those with CAD, or ...

A next-generation obesity drug candidate from Novo Nordisk produced modest weight loss, along with a higher rate of some ...

In a sample of people who regularly use ecstasy and other illicit stimulants, 54% reported using pharmaceutical stimulants ...

People with sickle cell are vulnerable to strokes caused by a blood vessel to the brain either bursting or becoming clogged, ...

Novo Nordisk today announced headline results from a phase 2a clinical trial with monlunabant, a small molecule oral cannabinoid receptor 1]. The trial investigated ...